Correspondence Between the Adult Treatment Panel III Criteria for Metabolic Syndrome and Insulin Resistance
Authors:
- 1 March 2006
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (3) , 668-672
Abstract
OBJECTIVE—The aim of the present study was to assess the diagnostic accuracy of the Adult Treatment Panel III (ATP-III) definition of the metabolic syndrome in identifying insulin-resistant individuals and to explore alternative approaches to improve identification of insulin-resistant individuals among asymptomatic adults from the general population. RESEARCH DESIGN AND METHODS—The sample consisted of 256 non-Hispanic white subjects without treated hypertension or diabetes, from the Rochester (Minnesota) Heart Family Study (123 men and 133 women; aged 20–60 years). Frequently sampled intravenous glucose tolerance tests were performed in all subjects. The reference standard for insulin resistance was determined by Bergman’s minimal model; insulin resistance was defined as an insulin sensitivity index −1 · μU−1 · ml−1. Component metabolic syndrome measures included blood pressure determined by sphygmomanometer; fasting serum triglycerides, HDL cholesterol, and glucose concentrations determined enzymatically; and waist circumference determined by tape measure. RESULTS—By ATP-III criteria, the prevalence of metabolic syndrome was 15.6% (16.3% in men and 15.1% in women; P = 0.465). The presence of metabolic syndrome had low sensitivity to identify insulin resistance (45% in men and 39% in women; sex difference, P = 0.137) but high specificity (93% in men and 95% in women; sex difference, P = 0.345). Based on the area under the receiver operating characteristic curve (AUC) constructed by counting metabolic syndrome components as recommended by ATP-III, diagnostic accuracy was fair (AUC = 0.797 in men and 0.747 in women). When component metabolic syndrome measures were considered as quantitative traits rather than dichotomized, use of waist circumference alone, rather than counting metabolic syndrome components, improved diagnostic accuracy for insulin resistance (in men, AUC = 0.906, P = 0.001; in women, AUC = 0.822, P = 0.10). CONCLUSIONS—Application of the ATP-III metabolic syndrome criteria provides good specificity but low sensitivity to screen asymptomatic white adults for insulin resistance. Measuring just waist circumference is simpler and may provide greater accuracy for identifying insulin resistance.Keywords
This publication has 13 references indexed in Scilit:
- Comparative evaluation of simple indices of insulin resistanceMetabolism, 2004
- Relationships between Insulin Sensitivity and Measures of Body Fat in Asymptomatic Men and WomenObesity Research, 2004
- The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goalsEndocrinology and Metabolism Clinics of North America, 2004
- Relationship to Insulin Resistance of the Adult Treatment Panel III Diagnostic Criteria for Identification of the Metabolic SyndromeDiabetes, 2004
- Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With DyslipidemiaDiabetes Care, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Repeatability of Insulin Sensitivity and Glucose Effectiveness From the Minimal Model: Implications for Study DesignDiabetes, 1994
- Repeatability of insulin sensitivity and glucose effectiveness from the minimal model. Implications for study designDiabetes, 1994
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988